« Zurück
Startseite /
Human Urokinase (uPA) AssayMax™ ELISA Kit

Human Urokinase (uPA) AssayMax™ ELISA Kit

ArtNr	EU1001-1
Hersteller	Assaypro
Menge	96 Well Plate
Kategorie	Oncology Food Safety Allergenes Drugs Proteins Neuroscience Metabolism Cholesterol & Lipid Metabolism Molecular Targets for Neuroscience Neural Signaling Neural Development ELISA Cardiovascular Research Atherosclerosis ELISA & Immunoassays ELISA Kits Immunoassay By Organ Breast Cancer
Typ	Elisa-Kit
Applikationen	ELISA
Specific against	Human (Homo sapiens)
Citations	* Fujiuchi Y et al. (2003) Effect of hepatocyte growth factor on invasion of prostate cancer cell lines. Oncol. Rep. 10(4):1001-1006 * Oka N et al. (2003) Amiloride and Urinary Trypsin Inhibitor Inhibit Urothelial Cancer Invasion. Eur Urol. 44(6):737-741 * Ueshima S et al. (2003) Suppression of the release of type-1 plasminogen activator inhibitor from human vascular endothelial cells by Hawaii deep sea water. Pathophysiology 9:103-109 * Uchima Y et al. (2004) Inhibition and Mechanism of Action of a Protease Inhibitor in Human Pancreatic Cancer Cells.??Pancreas 29(2):123-131 * Yamaguchi Y et al. (2004) Induction of uPA release in human peripheral blood lymphocytes by [deamino-Cysl,D-Arg8]-vasopressin (dDAVP). Am J Physiol Endocrinol Metab 287(5): E970-E976 * Nomuraa S et al. (2005) HMG-CoA Reductase Inhibitors Reduce Matrix Metalloproteinase-9 Activity in Human Varicose Veins. ?European Surgical Research 37(6):370-378 * Yamaguchi Y et al. (2005) Possible Involvement of Urokinase-Type Plasminogen Activator Release From Human Peripheral Blood Lymphocytes in the Pathophysiology of Chronic Allograft Nephropathy. Transplantation Proceedings. 37(10):4276-4281 * Cederqvist K et al. (2006) High Concentrations of Plasminogen Activator Inhibitor-1 in Lungs of Preterm Infants With Respiratory Distress Syndrome. Pediatrics 117(4):1226-1234 * Yang CC et al. (2007) In vitro regulation of adipogenesis: tunable engineered tissues. J Tissue Eng Regen Med. 1(2):146-153 * Yoshida C et al. (2007) Induction of urokinase-type plasminogen activator, interleukin-8 and early growth response-1 by STI571 through activating mitogen activated protein kinase in human small cell lung cancer cells. Blood Coagulation &, Fibrinolysis. 18(5):425-433 * Ogura Y et al. (2008) Plasmin induces degradation and dysfunction of laminin 332 (laminin 5) and impaired assembly of basement membrane at the dermal-epidermal junction. British Journal of Dermatology 159(1):49-60 * Ekmek?i OB et al. (2009) Effects of rhG-CSF Plus Dexamethasone on Hemostatic Parameters in Healthy Granulocyte Donors: Role of u-PA and Nitric Oxide. Clin. Appl. Thromb. Hemost. 15(6):689-694 * Okumura S et al. (2009) Hyperexpression of NOD2 in intestinal mast cells of Crohn's disease patients: Preferential expression of inflammatory cell-recruiting molecules via NOD2 in mast cells. Clin Immunol. 130(2):175-185 * Grzmil M (2010) An oncogenic role of eIF3e/INT6 in human breast cancer. Oncogene. 29(28):4080-4089 * Rasheed SA et al. (2010) First evidence that the antimalarial drug artesunate inhibits invasion and in vivo metastasis in lung cancer by targeting essential extracellular proteases. Int J Cancer. 127(6):1475-1485 * Sutoh T et al. (2010) Nafamostat Mesilate (FUT-175) Inhibits Cell Growth and Invasion of Malignant Pleural Mesothelioma Cell Line, MSTO-211H. Hirosaki Med. J. 61:19-25 * Wyr?bska A et al. (2012) Comparison of Anti-Invasive Activity of Parthenolide and 3-Isopropyl-2-Methyl-4-Methyleneisoxazolidin-5-One (MZ-6) ? A New Compound with -Methylene--Lactone Motif ? on Two Breast Cancer Cell Lines. Chemical Biology &, Drug Design 79(1):112-120 * Vieira ML et al. (2013) Interaction of Leptospira interrogans with Human Proteolytic Systems Enhances Dissemination through Endothelial Cells and Protease Levels. Infect Immun. 81(5):1764-74. doi: 10.1128/IAI.00020-13. Epub 2013 Mar 11 * Mahmoud AE and Ali MM (2014) Fermented Pomegranate (Punica granatum) Peel Extract as a Novel Anticancer Agent Targeting Angiogenesis and Metastasis. International Journal of toxicological and pharmacological research. 6(4):60-66
ECLASS 10.1	32160605
ECLASS 11.0	32160605
UNSPSC	41116126
Alias	uPA
Lieferbar
Manufacturer - Type	AssayMax™ ELISA Kits
Manufacturer - Category	ELISA_Activity_Kits
Associated Disease	Cancer
Description	This assay employs a quantitative enzyme immunoassay technique that measures the specified antigen in samples.
Note	For Research Use Only
Omim	191840
Unigene	Hs.77274
Format	Sandwich ELISA
Samples	Serum, Plasma, Cell Culture, Urine, Milk, Tissue Extract

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Arbeitsanleitung (Data Sheet) anfordern

Produkt-Datenblatt anfordern

EU1001-1-safety-datasheet.pdf